April 6 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T :
* GLOBAL PLASMA LEADERS COLLABORATE TO ACCELERATE DEVELOPMENT OF POTENTIAL COVID-19 HYPERIMMUNE THERAPY
* TAKEDA - BIOTEST, BPL, LFB, & OCTAPHARMA HAVE JOINED ALLIANCE BY CSL BEHRING, CO TO DEVELOP A POTENTIAL PLASMA-DERIVED THERAPY FOR TREATING COVID-19